Clinical Trials in Chicago

Showing 10221-10240 of 15,574 trials

Effect of Dexamethasone on Duration of Lower Extremity Blocks With Bupivacaine in Subjects Having ACL Repair

NCT01756560

Anterior cruciate ligament reapair is a painful procedure. Single shot femoral and sciatic nerve block only last 12-16 hrs. Since dexamethasone prolongs brachial plexus block, using it in lower extremity blocks will prolong the analgesia to provide better outpatient pain relief after surgery at home.

Duration of Pain Relief

University of Chicago2 participantsStarted Jan 2013

Chicago, Illinois, United States

COMPLETEDPhase 32.2 miles

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

NCT01539512

This Phase 3, randomized, double-blind, placebo-controlled study is to evaluate the effect of idelalisib in combination with rituximab on the onset, magnitude, and duration of tumor control in participants previously treated for chronic lymphocytic leukemia (CLL). Eligible patients will be randomized with a 1:1 ratio into 1 of the 2 treatment arms to receive either idelalisib plus rituximab or placebo plus rituximab. Participants who are tolerating primary study therapy but experience definitive CLL progression are eligible to receive active idelalisib therapy in the extension study, GS-US-312-0117.

Chronic Lymphocytic Leukemia

Gilead Sciences220 participantsStarted Apr 2012

Huntsville, Alabama, United States • Tucson, Arizona, United States • La Jolla, California, United States +69 more locations

Effect of Dexamethasone on Duration of Lower Extremity Blocks With Bupivacaine in Subjects Having ACL Repair

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Find Trials by Condition in Chicago

A Study for Patients With Acute Leukemia

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

Early DHA Supplementation in Very Low Birth Weight Infants

Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Sodium Management in Acute Neurological Injury

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

Melody® Transcatheter Pulmonary Valve Post-Approval Study

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Operative Versus Nonoperative Treatment of Humeral Shaft Fractures: A Prospective Cohort Comparison Study

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Fenzian Asthma Multicenter Outcomes Study